The Journal of Immunology, Vol 144, Issue 9 3367-3374, Copyright © 1990 by American Association of Immunologists

ARTICLES

Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope

CD Surh, R Coppel and ME Gershwin
Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis 95616.

The E2 component (acetyltransferase) of the pyruvate dehydrogenase (PDH) complex is the major mitochondrial autoantigen recognized by autoantibodies in patients with primary biliary cirrhosis (PBC). Previous work, using only a partial length rat liver cDNA clone of PDH- E2, demonstrated that the immunodominant epitope was localized to the lipoic acid binding site. Human PDH-E2, in contrast to rat PDH-E2, has two lipoic acid binding sites. By using a full length human cDNA for PDH-E2, and by preparation of multiple overlapping recombinant fragments, we have determined that three autoreactive determinants are present on human PDH-E2: two cross-reactive lipoyl domains, and an area surrounding the E1/E3 binding region. The dominant epitope was localized to the inner lipoyl domain whereas the outer lipoyl domain only showed a weak cross-reactivity, and only 1/26 PBC sera reacted weakly to the E1/E3 binding region area. By probing recombinant fusion proteins expressed from small restriction fragments of the inner lipoyl domain, we have found that a minimum of 75 amino acids (residues 146- 221) were required for detectable autoantibody binding, and that 93 amino acids (residues 128-221) were necessary for characteristically strong antimitochondrial autoantibody recognition. Such a requirement for a large region suggests the possibility that a conformational autoepitope may be recognized. In addition, we have found that absorption of PBC sera with the purified mammalian PDH complex does not remove reactivity against Escherichia coli Ag. The possible implications for such results are discussed.

This article has been cited by other articles:

				R. Bellucci, S. Oertelt, M. Gallagher, S. Li, E. Zorn, E. Weller, F. Porcheray, E. P. Alyea, R. J. Soiffer, N. C. Munshi, et al. Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis Blood, March 1, 2007; 109(5): 2001 - 2007. [Abstract] [Full Text] [PDF]

				K. Amano, P. S. C. Leung, R. Rieger, C. Quan, X. Wang, J. Marik, Y. F. Suen, M. J. Kurth, M. H. Nantz, A. A. Ansari, et al. Chemical Xenobiotics and Mitochondrial Autoantigens in Primary Biliary Cirrhosis: Identification of Antibodies against a Common Environmental, Cosmetic, and Food Additive, 2-Octynoic Acid J. Immunol., May 1, 2005; 174(9): 5874 - 5883. [Abstract] [Full Text] [PDF]

				K. Amano, P. S. C. Leung, Q. Xu, J. Marik, C. Quan, M. J. Kurth, M. H. Nantz, A. A. Ansari, K. S. Lam, M. Zeniya, et al. Xenobiotic-Induced Loss of Tolerance in Rabbits to the Mitochondrial Autoantigen of Primary Biliary Cirrhosis Is Reversible J. Immunol., May 15, 2004; 172(10): 6444 - 6452. [Abstract] [Full Text] [PDF]

				D E J Jones Autoantigens in primary biliary cirrhosis J. Clin. Pathol., November 1, 2000; 53(11): 813 - 821. [Abstract] [Full Text] [PDF]

				C. Migliaccio, A. Nishio, J. Van de Water, A. A. Ansari, P. S. C. Leung, Y. Nakanuma, R. L. Coppel, and M. E. Gershwin Monoclonal Antibodies to Mitochondrial E2 Components Define Autoepitopes in Primary Biliary Cirrhosis J. Immunol., November 15, 1998; 161(10): 5157 - 5163. [Abstract] [Full Text] [PDF]

				D. Yang, J. Song, T. Wagenknecht, and T. E. Roche Assembly and Full Functionality of Recombinantly Expressed Dihydrolipoyl Acetyltransferase Component of the Human Pyruvate Dehydrogenase Complex J. Biol. Chem., March 7, 1997; 272(10): 6361 - 6369. [Abstract] [Full Text] [PDF]